Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine
Clinical trial NCT05433285 · COMPLETED
Trial details
- NCT number
- NCT05433285
- Sponsor
- PT Bio Farma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-07
- Primary completion
- 2022-08-05
- Enrollment
- 4050
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.